Product image of Montelukast Bluefish (Montelukast) supplied by GNH India

Montelukast Bluefish

Active Ingredient:
Montelukast
Origin:
EU

Montelukast Bluefish (Montelukast)

Montelukast, the active ingredient in Montelukast Bluefish, is a leukotriene receptor antagonist presented as an oral dosage form for oral use. It is employed to manage asthma, allergic rhinitis, and exercise‑induced bronchoconstriction in adults and children as directed by a healthcare professional. The medication is formulated to be taken once daily, with or without food, and is available in tablet form complying with EU regulatory standards.

GNH India supplies Montelukast Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Bluefish Pharmaceuticals Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Montelukast acts on the leukotriene pathway to control airway inflammation and bronchoconstriction.
  • Asthma: reduces frequency of wheezing episodes and improves overall lung function.
  • Allergic rhinitis: alleviates nasal congestion, sneezing and itching caused by allergen exposure.
  • Exercise‑induced bronchoconstriction: prevents narrowing of the airways during or after physical activity.
  • Seasonal allergic rhinitis: provides symptom relief during pollen seasons.

How It Works

  • Montelukast selectively blocks the cysteinyl leukotriene receptor type 1 (CysLT1) on airway smooth‑muscle cells, mast cells and eosinophils. By preventing leukotriene D4 and related mediators from binding, it inhibits the cascade that leads to bronchoconstriction, mucus secretion, vascular permeability and inflammatory cell recruitment, thereby reducing airway hyper‑responsiveness and allergic inflammation. The antagonism is dose‑dependent and persists for 24 hours, supporting once‑daily dosing.

Side Effects

Montelukast may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Headache: mild to moderate headache reported in clinical use.
  • Abdominal pain: occasional stomach discomfort or cramps.
  • Nausea: feeling of queasiness without vomiting.
  • Cough: transient dry cough.
  • Dizziness: light‑headed sensation.
  • Fatigue: unusual tiredness.

Serious or Rare Side Effects

  • Allergic reactions: rash, angioedema or anaphylaxis requiring immediate medical attention.
  • Neuropsychiatric events: mood changes, depression, or suicidal thoughts.
  • Hepatic enzyme elevation: abnormal liver function tests indicating possible liver involvement.

Precautions & Warnings

When prescribing Montelukast, clinicians should consider several precautionary measures to ensure safe use.

  • Assess liver function: evaluate hepatic status before initiating therapy, especially in patients with known liver disease.
  • Monitor neuropsychiatric symptoms: watch for mood changes, depression, or suicidal ideation during treatment.
  • Use caution in severe hepatic impairment: dose adjustment may be required or alternative therapy considered.
  • Avoid in known hypersensitivity: discontinue if allergic reaction to Montelukast or any excipients occurs.
  • Consider renal function: adjust dosing in patients with significant renal impairment as recommended.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Montelukast can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

  • Ritonavir: strong CYP3A4 inhibition can increase Montelukast plasma levels.
  • Ketoconazole: potent CYP3A4 inhibitor may raise drug exposure.
  • Erythromycin: macrolide antibiotic that can elevate Montelukast concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential alteration of anticoagulant effect; monitor INR.
  • Theophylline: may experience increased side effects; observe respiratory status.
  • Corticosteroids: concurrent use may enhance immunosuppressive risk; assess clinical response.

Frequently Asked Questions

Montelukast Bluefish contains the active ingredient Montelukast, which is prescribed to treat asthma, allergic rhinitis and exercise‑induced bronchoconstriction. It works by reducing airway inflammation and preventing bronchospasm, helping patients achieve better breathing control and fewer allergy‑related symptoms.

Montelukast selectively blocks the cysteinyl leukotriene receptor type 1 (CysLT1) on cells in the respiratory tract. By preventing leukotrienes from binding, it stops the cascade that causes bronchoconstriction, mucus production, vascular leakage and inflammatory cell recruitment, thereby easing airway narrowing and allergic inflammation.

The appropriate dose of Montelukast is determined by the prescribing clinician based on the patient’s age, condition and overall health. Common regimens include a once‑daily tablet, but the exact strength and schedule should follow the prescriber’s instructions and local labeling requirements.

Safety data for Montelukast during pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Healthcare providers should weigh potential benefits against possible risks and discuss any concerns with the patient before prescribing it to pregnant or nursing women.

To request Montelukast Bluefish, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, offering an oral alternative to inhaled corticosteroids or long‑acting beta‑agonists for asthma control. Unlike steroids, it does not suppress the immune system, but it may be less potent for severe asthma, so clinicians often use it as add‑on therapy or for patients preferring oral medication.

Montelukast Bluefish tablets should be stored at room temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid exposing it to extreme heat or humidity.

Montelukast is taken orally, usually as a tablet, once daily. It can be swallowed with or without food, and the exact time of day should be consistent to maintain steady blood levels. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious risks include neuropsychiatric events such as mood changes, depression or suicidal thoughts, as well as severe allergic reactions like angioedema or anaphylaxis. Liver enzyme elevations have also been reported. Patients should seek immediate medical attention if they experience any of these symptoms.

Montelukast should be avoided in individuals with known hypersensitivity to the drug or any of its excipients. Caution is advised for patients with severe hepatic impairment, and it may not be appropriate for those with uncontrolled psychiatric conditions without close monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Montelukast

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT